Van C Willis Selected Research

Complement 3b Receptors

2/2015

A new mouse anti-mouse complement receptor type 2 and 1 (CR2/CR1) monoclonal antibody as a tool to study receptor involvement in chronic models of immune responses and disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Van C Willis Research Topics

Disease

4	Arthritis (Polyarthritis) 02/2015 - 04/2011
3	Rheumatoid Arthritis 10/2013 - 04/2011
2	Experimental Arthritis 02/2015 - 04/2011
1	Breast Neoplasms (Breast Cancer) 07/2021
1	Infections 12/2020
1	COVID-19 12/2020
1	Cytokine Release Syndrome 12/2020
1	Microsatellite Instability 10/2020
1	Colonic Neoplasms (Colon Cancer) 10/2020
1	Autoimmune Diseases (Autoimmune Disease) 02/2015
1	Endometrial Neoplasms (Endometrial Cancer) 01/2013
1	Endometrial Hyperplasia 01/2013
1	Hyperplasia 01/2013
1	Neoplasms (Cancer) 01/2013

Drug/Important Bio-Agent (IBA)

2	AutoantibodiesIBA 10/2013 - 04/2011
2	Proteins (Proteins, Gene)FDA Link 02/2013 - 04/2011
1	Antiviral Agents (Antivirals)IBA 12/2020
1	Pharmaceutical PreparationsIBA 12/2020
1	AntibodiesIBA 02/2015
1	Collagen Type II (Type II Collagen)IBA 02/2015
1	Complement 3b ReceptorsIBA 02/2015
1	Immunoglobulin G (IgG)IBA 02/2015
1	Anti-Citrullinated Protein AntibodiesIBA 10/2013
1	Fibrinogen (Factor I)FDA Link 02/2013
1	CitrullineIBA 02/2013
1	Arginine (L-Arginine)FDA Link 02/2013
1	Estrogens (Estrogen)FDA Link 01/2013
1	Protein Kinase CIBA 01/2013
1	Estrogen ReceptorsIBA 01/2013
1	ElementsIBA 01/2013
1	CollagenIBA 04/2011
1	AmidesIBA 04/2011
1	Protein-Arginine DeiminasesIBA 04/2011
1	N- alpha- benzoyl- N5- (2- chloro- 1- iminoethyl)- L- ornithine amideIBA 04/2011

Therapy/Procedure

1	Mastectomy (Mammectomy) 07/2021
1	Therapeutics 12/2020
1	Drug Therapy (Chemotherapy) 10/2020
1	Adjuvant Chemotherapy 10/2020